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dial injury and subsequent clinical outcomes in STEMI is unclear. We
investigated the effect of platelet count on microvascular obstruction
(MVO), infarct size (IS) and major adverse cardiac events (MACE) in
patients with large anterior STEMI undergoing primary percutaneous
coronary intervention enrolled in the INFUSE-AMI trial.
METHODS Participants from INFUSE-AMI were categorized according to
platelet count tertiles at clinical presentation. Primary endpoints were
cardiac magnetic resonance (MRI) assessed MVO (percentage of left ven-
tricular [LV] mass) at 5 days and IS (% of LV mass) at 30 days. Secondary
endpoint was the rate of major adverse cardiac events (MACE) at 1 year,
deﬁned as the composite of death, reinfarction, new-onset heart failure
(HF) or re-hospitalization for HF. Multivariable regression analysis was
used to evaluate the correlation between PC andMACE at 1 year.
RESULTS Of 447 patients enrolled in the INFUSE-AMI study, 135, 137 and
136weredistributed in the 1st (PC216105/mL), 2nd (PC>216 to266105/mL)
and 3rd tertile (PC >266105/mL), respectively. Patients with lower PC were
older,morecommonlymale,andhad lowerwhitebloodcell countatbaseline.
At 5 days, there were no differences in median MVO across platelet tertiles
(0.3% vs. 0.8% vs. 0.7%; p ¼ 0.86). Similarly, at 30 days there were no dif-
ferences in median IS (17.4% vs. 17.1% vs. 17.7%; p ¼ 0.84). Following multi-
variable adjustment, PC still had no effect on 30-daymyocardial IS (p¼ 0.78).
Finally, while unadjusted analysis demonstrated no difference in 1-year
MACE rates across platelet tertiles (11.3% vs. 10.4% vs. 10.0%; p ¼ 0.81),
following adjustment lower PC was associated with increased risk of 1-year
MACE (per each 100.000/mL decrease; Hazard Ratio¼1.06; 95% CI: 1.01 – 1.12;
p¼ 0.03).
CONCLUSIONS In patients with large anterior STEMI, baseline
platelet count did not have an effect on MVO and infarct size assessed
by MRI. However, lower PC correlated with higher risk of MACE at 1
year. Further studies are required to explore the role of thrombocy-
topenia in the prognosis of patients with STEMI.
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BACKGROUND Patients with non-anterior ST-segment elevation
myocardial infarction (NA-STEMI) have better prognosis than those
with anterior STEMI (A-STEMI). In contrast to A-STEMI, little is known
regarding factors affecting long-term prognosis in patients with NA-
STEMI. We therefore sought to determine the clinical and angio-
graphic predictors of long-term mortality in patients with NA-STEMI
undergoing primary percutaneous coronary intervention (PPCI).
METHODS Participants from the HORIZONS-AMI trial were catego-
rized according to ECG-deﬁned ST-segment elevation location in NA-
STEMI and A-STEMI. By the ECG core laboratory, NA-STEMI was
deﬁned as ST elevation in the lateral (V5, V6, I, aVL), inferior (II, III,
aVF), infero-lateral (I, II, III, aVF and V5-V6) or antero-lateral (V3 – V6,
I, aVL) ECG leads. Independent predictors of mortality at 3 years were
identiﬁed by Cox proportional hazards modeling including clinical
variables (clinical model), quantitative coronary angiography (QCA)
variables (QCA model), and both (combined model).
RESULTS Among 2,578 patients undergoing PPCI with core laboratory
determined STEMI location, 1,813 (70.3%) had NA-STEMI. Comparedwith
A-STEMI, NA-STEMI patients were younger, more commonly smokers,
and had higher baseline left ventricular ejection fraction (LVEF). In pa-
tientswith NA-STEMI, 84 deaths (4.8%) occurredwithin 3 years of follow-
up. Clinical variables independently associated with 3-year all-cause
mortality in NA-STEMIwere age, Killip Class, peripheral vascular disease,
hemoglobin, platelet count, white blood cell count, symptom-to-balloon
time and heart rate at presentation. In the QCA model, the only variable
independently associated with mortality was baseline LVEF. Signiﬁcant
predictors in the combined model are shown in Table 1.Combined clinical and QCA multivariable model for 3-year mortality in patients with non-anterior STEMI.Independent predictors of 3-year
mortality HR [95% CI] p-valueAge (per year increase) 1.07 [1.04 - 1.10] <0.0001Killip class (per each class
increase)2.03 [1.32 – 3.13] 0.001White blood cell count (per
10.000/mL increase)1.12 [1.03 - 1.21] 0.006Symptom to balloon time (per
30 minutes increase)1.03 [1.02 - 1.04] <0.0001LVEF (per each % decrease) 1.03 [1.00 – 1.06] 0.02LVEF: Left Ventricular Ejection Fraction
CONCLUSIONS In the HORIZONS-AMI trial, patients with NA-STEMI
had a lower clinical risk proﬁle and higher LVEF compared with A-
STEMI. Although generally considered low risk, a combination of
readily available clinical and QCA variables identify NA-STEMI pa-
tients who are at increased risk for mortality after primary PCI.
CATEGORIES CORONARY: Acute Myocardial Infarction
KEYWORDS Predictors, ST-segment elevation myocardial infarction
TCT-267
Agreement Between Pre-Hospital and Emergency Department ECG in the
Diagnosis of STEMI – Patterns of Concordance and Discordance
Tri M. Trinh,1 Nichole Bosson,1 Andrea Fang,1 Amy Kaji,1
Joseph Thomas,1 David Shavelle,2 William J. French,1
James T. Niemann1
1Harbor UCLA Medical Center, Torrance, CA; 2University of Southern
California, Los Angeles, CA
BACKGROUND Pre-hospital (PH) ECG enables ﬁeld diagnosis and
triage of STEMI patients to specialized STEMI receiving centers.
Despite the proven beneﬁts of early identiﬁcation, false-positive ECG
interpretations and unnecessary cardiac catheterization laboratory
activations remain a common, challenging problem. We report the
incidence and patterns of agreement between PH and Emergency
Department (ED) ECGs in a large regional STEMI system of care.
METHODS A total of 34 hospitals provide primary PCI as part of a region-
alized STEMI systemof care in Los Angeles County. Each facility is required
to enter data into a county-wide registry of all patientswith possible STEMI
transported by emergency medical services. PH ECG diagnosis of STEMI is
based on software interpretation. ED diagnosis of STEMI is determined by
the receiving physician. Registry data was analyzed for all patients treated
in this system from 2011 to 2014. McNemar’s test was used to assess the
signiﬁcance of the difference between the two correlated proportions.
RESULTS There were 16771 STEMI cases in the registry over four years.
Either the PH or ED ECG was not obtained or not documented in 1358
patients (8%). For cases where both ECG interpretationswere available,
87% (13512/15413) of PH ECG were positive for STEMI, whereas 44%
(6732/15413) of ED ECGwere positive for STEMI (Table 1). Disagreement
occurred in 57% of cases. The most common pattern was discordance
with positive PHECG and negative ED ECG for STEMI. The odds ratio for
discordance was 7.5, 95%CI 7-8, p<0.00001. The high rate of discor-
dance between positive PH and negative ED ECGwas attributed to poor
quality ECG (1770, 23%), dysrhythmia (2032, 26%), mimics such as
pericarditis, hyperkalemia, and Brugada (800, 10%), early repolariza-
tion (188, 2%), vasospasm (5, 0.1%), or undocumented (3026, 39%).
Despite the high frequency of false positive ECGs, a total of 7355 pa-
tients underwent cardiac catheterization. PCI was performed in 5624
and 71 patients received thrombolytic therapy.
CONCLUSIONS Disagreement between PH and ED ECGs is the rule,
not the exception. Reducing false positive PH ECG results will require
improved technology, earlier provider review of PH ECGs and incor-
poration of clinical data into the STEMI activation algorithm.
Table 1. Concordance and Discordance of ECGsED Positive ED Negative TotalPH Positive 5691 7821 13512PH Negative 1041 860 19016732 8681 15413CATEGORIES CORONARY: Acute Myocardial Infarction
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